Last updated date
ABOUT THIS STUDY
Open-label, multicenter, multiple-dose, study of population pharmacokinetics of I.V. Synercid (7.5 mg/kg every 8 hours) in 75 pediatric patients. The purpose is to assess the population pharmacokinetics of Synercid in pediatric patients and to collect additional safety and efficacy data in pediatric patients.
Oakland, California, 94609, United States
Gram-Positive Bacterial Infections
Females and Males
27 + weeks
- Serious, suspected or documented gram-positive infection
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Gram-Positive Bacterial InfectionsOpen-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
- Oakland, California
- Orange, California
- Durham, North Carolina
- Cincinnati, Ohio
- Cleveland, Ohio
- Tulsa, Oklahoma
Gram-Positive Bacterial InfectionsStudy Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
Gram-Positive Bacterial InfectionsPost Marketing Surveillance Study on Linezolid